The latest closing stock price for United Therapeutics as of May 16, 2025 is 305.35.
An investor who bought $1,000 worth of United Therapeutics stock at the IPO in 1999 would have $49,108 today, roughly 49 times their original investment - a 16.25% compound annual growth rate over 26 years.
The all-time high United Therapeutics stock closing price was 410.00 on November 08, 2024.
The United Therapeutics 52-week high stock price is 417.81, which is 36.8% above the current share price.
The United Therapeutics 52-week low stock price is 264.33, which is 13.4% below the current share price.
The average United Therapeutics stock price for the last 52 weeks is 335.49.
An investor who bought $1,000 worth of United Therapeutics stock at the IPO in 1999 would have $49,108 today, roughly 49 times their original investment - a 16.25% compound annual growth rate over 26 years.
The all-time high United Therapeutics stock closing price was 410.00 on November 08, 2024.
The United Therapeutics 52-week high stock price is 417.81, which is 36.8% above the current share price.
The United Therapeutics 52-week low stock price is 264.33, which is 13.4% below the current share price.
The average United Therapeutics stock price for the last 52 weeks is 335.49.